Atlas Venture Fund X, L.P. Kymera Therapeutics, Inc. (KYMR) insider trading activity

Atlas Venture Fund X, L.P. is of Kymera Therapeutics, Inc.. Currently has a direct ownership of 4.68 Million shares of KYMR, which is worth approximately $216 Million. The most recent transaction as insider was on Mar 13, 2024, when has been sold 115,090 shares (Common Stock) at a price of $42.51 per share, resulting in proceeds of $4,892,475. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.68M

0% 3M change

5.88% 12M change

Total Value Held $216 Million

Atlas Venture Fund X, L.P. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 13 2024	SELL Open market or private sale	$4,892,475 $42.51 p/Share	115,090 Reduced 2.4%	4,676,075 Common Stock
Mar 12 2024	SELL Open market or private sale	$5,686,142 $42.23 p/Share	134,647 Reduced 2.73%	4,791,165 Common Stock
Mar 11 2024	SELL Open market or private sale	$1,822,793 $43.09 p/Share	42,302 Reduced 0.85%	4,925,812 Common Stock
Jan 12 2023	SELL Open market or private sale	$2,336,207 $30.29 p/Share	77,128 Reduced 1.53%	4,968,114 Common Stock
Jan 11 2023	SELL Open market or private sale	$649,622 $29.96 p/Share	21,683 Reduced 0.43%	5,045,242 Common Stock
Dec 15 2022	SELL Open market or private sale	$76,830 $30.0 p/Share	2,561 Reduced 0.05%	5,066,925 Common Stock
Dec 14 2022	SELL Open market or private sale	$9,557,365 $32.28 p/Share	296,077 Reduced 5.52%	5,069,486 Common Stock
Nov 03 2022	SELL Open market or private sale	$2,259,360 $30.0 p/Share	75,312 Reduced 1.38%	5,365,563 Common Stock
Nov 02 2022	SELL Open market or private sale	$2,899,361 $30.02 p/Share	96,581 Reduced 1.74%	5,440,875 Common Stock
Nov 01 2022	SELL Open market or private sale	$1,855,411 $30.83 p/Share	60,182 Reduced 1.08%	5,537,456 Common Stock
Oct 31 2022	SELL Open market or private sale	$2,848,844 $30.23 p/Share	94,239 Reduced 1.66%	5,597,638 Common Stock
Oct 28 2022	SELL Open market or private sale	$2,134,050 $30.0 p/Share	71,135 Reduced 1.23%	5,691,877 Common Stock
May 18 2021	SELL Other acquisition or disposition	-	1,122,619 Reduced 16.3%	5,763,012 Common Stock
Feb 18 2021	SELL Other acquisition or disposition	-	1,063,351 Reduced 13.38%	6,885,631 Common Stock

Also insider at

GBIO

Generation Bio Co. Healthcare

> 10% Shareholder

MGTA

Magenta Therapeutics, Inc. Healthcare

> 10% Shareholder

IKNA

Ikena Oncology, Inc. Healthcare

> 10% Shareholder

GMTX

Gemini Therapeutics, Inc. Healthcare

> 10% Shareholder

AVF